首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1508795

標靶藥物傳輸市場：依疾病類型、依應用、依最終使用者、按地區

Targeted Drug Delivery Market, By Disease Type, By Application, By End User, By Geography

出版日期: 2024年06月04日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球標靶給藥市場價值為92.2億美元，預計到2031年將達到262.4億美元，2024年至2031年複合年成長率為16.1%。

圖 1. 2024 年按地區分類的標靶藥物輸送市場佔有率(%)

標靶藥物遞送是指將藥物化合物直接遞送至體內的標靶作用位點，從而最大限度地提高治療效果並最大限度地減少副作用。它涉及藥物與識別特定細胞表面受體或抗原的靶向配體或部分的封裝或綴合。這使得藥物載體系統能夠選擇性地靶向體內患病細胞和組織，提高藥物在作用部位的生物有效性並減少全身副作用。標靶藥物傳遞在有效治療多種慢性疾病（包括癌症、心血管疾病和神經系統疾病）方面具有巨大潛力，因為它能夠使藥物發揮作用於位特異性。

市場動態：

標靶給藥市場主要是由全球慢性病盛行率不斷上升、對具有卓越功效和安全性的精準藥物的需求不斷成長以及製藥公司對先進標靶給藥技術的研究增加的開發投資所推動的。此外，容易患慢性病的老年人口不斷增加、奈米藥物和標靶治療的持續研究、新型標靶藥物製劑的監管核准等都是為市場參與者創造利潤豐厚機會的關鍵因素。然而，與標靶遞送系統相關的高開發成本、新興國家缺乏適當的臨床研究基礎設施以及標靶藥物配方的複雜性是限制快速採用的主要挑戰。行業專家和研究人員為開發負擔得起且穩定的有針對性的交付解決方案而做出的各種努力可能有助於在未來幾年克服這些限制。

本研究的主要特點

該報告對全球靶向給藥市場進行了詳細分析，以2023年為基準年估計了預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、業績和策略等參數，包括全球靶向藥物輸送市場的主要公司概況。
主要企業包括艾伯維公司、賽諾菲公司、Arrowhead Pharmaceuticals, Inc.、巴克斯特國際公司、阿斯特捷利康公司、波士頓科學公司、Depomed, Inc.、Fraunhofer Gesellschaft Munchen、Janssen Global Services, LLC、綠葉製藥集團及輝瑞。
該報告的見解將幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球靶向給藥市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球標靶給藥市場的各種策略矩陣來促進決策。

公司簡介
- AbbVie Inc.
- Sanofi
- Arrowhead Pharmaceuticals, Inc.
- Baxter International Inc.
- AstraZeneca
- Boston Scientific Corporation
- Depomed, Inc.
- Fraunhofer Gesellschaft Munchen
- Janssen Global Services, LLC
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Taiwan Liposome Company, Ltd.
- Vectura Group PLC

第10章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5003

Global targeted drug delivery market is estimated to be valued at USD 9.22 Bn in 2024 and is expected to reach USD 26.24 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.1% from 2024 to 2031.

Figure 1. Targeted Drug Delivery Market Share (%), By Region, 2024

Targeted drug delivery refers to the delivery of pharmaceutical compounds directly to the targeted sites of action in the body, thus maximizing the therapeutic effects and minimizing the side effects. It involves the encapsulation or conjugation of drugs with targeting ligands or moieties that recognize specific cell-surface receptors or antigens. This allows the drug carrier system to selectively target the diseased cells or tissues in the body, thereby increasing the bioavailability of drugs at the site of action and reducing systemic side effects. Targeted drug delivery holds tremendous potential for the effective management of various chronic diseases like cancer, cardiovascular ailments, neurological disorders, etc. as it allows site-specific action of drugs.

Market Dynamics:

The targeted drug delivery market is primarily driven by the rising prevalence of chronic diseases globally, boosting the demand for precision medicines with superior efficacy and safety profiles, increasing R&D investments by pharmaceutical companies in advanced drug delivery technologies. Furthermore, the growing geriatric population susceptible to chronic health conditions, ongoing research on nanomedicines and targeted therapies, and regulatory approvals of novel targeted drug formulations are some key factors creating lucrative opportunities for market players. However, high development costs associated with targeted delivery systems, lack of proper infrastructure for clinical research in emerging nations, and complexity of targeted drug formulations are major challenges restraining the rapid adoption. Various initiatives by industry experts and researchers to develop affordable and stable targeted delivery solutions can help overcome these limitations in the coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global targeted drug delivery market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global targeted drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes AbbVie Inc., Sanofi , Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca , Boston Scientific Corporation, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC, Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Taiwan Liposome Company, Ltd., and Vectura Group PLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global targeted drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global targeted drug delivery market.

Detailed Segmentation-

By Disease Type:
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
By Application:
- First Order Targeting
- Second Order Targeting
- Third Order Targeting
By End User:
- Hospitals
- Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AbbVie Inc.
- Sanofi
- Arrowhead Pharmaceuticals, Inc.
- Baxter International Inc.
- AstraZeneca
- Boston Scientific Corporation
- Depomed, Inc.
- Fraunhofer Gesellschaft Munchen
- Janssen Global Services, LLC
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Taiwan Liposome Company, Ltd.
- Vectura Group PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Targeted Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Targeted Drug Delivery Market, By Disease Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pulmonary Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Endocrine Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Targeted Drug Delivery Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
First Order Targeting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Second Order Targeting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Third Order Targeting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Targeted Drug Delivery Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Targeted Drug Delivery Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- AbbVie Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Arrowhead Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter International Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Depomed, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fraunhofer Gesellschaft Munchen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Janssen Global Services, LLC
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Taiwan Liposome Company, Ltd.
- Vectura Group PLC